Varex Imaging Corporation
(VREX)
undefined
undefined%
At close: undefined
14.52
0.21%
After-hours Jan 06, 2025, 04:22 PM EST
Varex Imaging Corporation Revenue Breakdown
| Quarter | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 29, 2023 |
|---|---|---|---|---|
| Industrial Segment Revenue | 61.30M | 60.50M | 57.40M | 50.10M |
| Industrial Segment Revenue Growth | +1.32% | +5.40% | +14.57% | n/a |
| Medical Segment Revenue | 144.40M | 148.60M | 148.80M | 139.90M |
| Medical Segment Revenue Growth | -2.83% | -0.13% | +6.36% | n/a |
Revenue by Geography
| Quarter | Sep 27, 2024 | Sep 29, 2023 | Sep 30, 2022 | Oct 1, 2021 | Oct 2, 2020 | Sep 27, 2019 | Sep 28, 2018 | Sep 29, 2017 |
|---|---|---|---|---|---|---|---|---|
| Americas Revenue | 266.50M | 281.80M | 273.30M | 268.50M | 251.80M | 229.00M | 243.10M | 239.80M |
| Americas Revenue Growth | -5.43% | +3.11% | +1.79% | +6.63% | +9.96% | -5.80% | +1.38% | n/a |
| Asia Pacific Revenue | 264.20M | 320.90M | 305.30M | 273.30M | 231.50M | 269.00M | 254.50M | 238.80M |
| Asia Pacific Revenue Growth | -17.67% | +5.11% | +11.71% | +18.06% | -13.94% | +5.70% | +6.57% | n/a |
| Emea Revenue | 280.30M | 290.70M | 280.80M | 276.30M | 249.80M | 275.30M | 268.80M | 219.50M |
| Emea Revenue Growth | -3.58% | +3.53% | +1.63% | +10.61% | -9.26% | +2.42% | +22.46% | n/a |
| United States Revenue | 257.70M | 275.10M | 263.70M | 262.30M | n/a | n/a | n/a | n/a |
| United States Revenue Growth | -6.32% | +4.32% | +0.53% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Quarter | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 29, 2023 | Sep 29, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 30, 2022 | Sep 30, 2022 | Jul 1, 2022 | Apr 1, 2022 | Dec 31, 2021 | Oct 1, 2021 | Jul 2, 2021 | Apr 2, 2021 | Jan 1, 2021 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Jan 3, 2020 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 28, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 29, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 30, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 34.30M | 35.60M | 35.50M | 32.40M | 31.90M | 32.10M | 34.10M | 30.30M | 29.70M | 30.20M | 25.30M | 33.10M | 31.30M | 29.20M | 30.60M | 34.40M | 40.70M | 31.40M | 35.30M | 34.80M | 35.80M | 35.20M | 31.10M | 30.80M | 32.20M | 35.20M | 30.90M | 28.20M | 29.20M | 26.30M | 19.70M | 26.90M | 22.30M | 20.60M | 20.80M | 22.00M | 18.60M |
| Selling, General, and Administrative Revenue Growth | -3.65% | +0.28% | +9.57% | +1.57% | -0.62% | -5.87% | +12.54% | +2.02% | -1.66% | +19.37% | -23.56% | +5.75% | +7.19% | -4.58% | -11.05% | -15.48% | +29.62% | -11.05% | +1.44% | -2.79% | +1.70% | +13.18% | +0.97% | -4.35% | -8.52% | +13.92% | +9.57% | -3.42% | +11.03% | +33.50% | -26.77% | +20.63% | +8.25% | -0.96% | -5.45% | +18.28% | n/a |
| Research and Development Revenue | 21.90M | 22.00M | 22.60M | 20.50M | 21.80M | 20.00M | 23.00M | 20.00M | 20.20M | 20.20M | 18.90M | 17.70M | 17.80M | 19.20M | 18.20M | 16.70M | 17.30M | 19.00M | 20.90M | 21.70M | 19.60M | 20.90M | 18.80M | 18.80M | 20.70M | 20.50M | 22.00M | 19.70M | 21.90M | 17.70M | 14.40M | 13.30M | 13.90M | 14.00M | 13.10M | 12.50M | 15.70M |
| Research and Development Revenue Growth | -0.45% | -2.65% | +10.24% | -5.96% | +9.00% | -13.04% | +15.00% | -0.99% | n/a | +6.88% | +6.78% | -0.56% | -7.29% | +5.49% | +8.98% | -3.47% | -8.95% | -9.09% | -3.69% | +10.71% | -6.22% | +11.17% | n/a | -9.18% | +0.98% | -6.82% | +11.68% | -10.05% | +23.73% | +22.92% | +8.27% | -4.32% | -0.71% | +6.87% | +4.80% | -20.38% | n/a |